GLP1R and diabetic kidney disease: Therefore, the anti-inflammatory and antiapoptotic effect of sitagliptin can be related to direct activation of GLP-1 receptor, highlighting the importance of sitagliptin as a therapeutic agent for diabetic nephropathy.